Evaluate

November 26, 2019

Cymabay is out, but for Genfit the band plays on

A day after seladelpar is canned over toxicity fears elafibranor passes a safety review, but should Genfit holders worry all the same?

August 25, 2016

Siponimod rides to Novartis’s rescue

October 28, 2014

Receptos might not fly solo for much longer

August 23, 2012

Investors breathe sigh of relief on SkyePharma bond move

July 03, 2012

Astellas can relax as overactive bladder drug is approved

April 13, 2012

Therapeutic focus - Amgen buys novel kidney disease treatment as bundling bites

April 10, 2012

Event - Astellas looks to hold onto UI franchise after adcom vote

October 27, 2010

Phenomix departure points to shrinking DPP-IV field